MRAM Q1 2026 Earnings EPS Beats Estimates by 19 Stock Edges Higher JKS Q4 2025 Earnings Significant EPS Miss Despite Modest Share Gain FGN Q1 2026 Earnings EPS Misses Analyst Estimates Amid Market Volatility LYB Q1 2026 Earnings Strong EPS Surprise of 140 as Cost Optimization Drives Results Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management TPST Q1 2026 Earnings Significant EPS Miss Amid No Revenue Stock Gains 276